Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other 7Genitourinary 7Gastrointestinal 5Breast 3CNS 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Brain Neoplasms 1905Glioblastoma 1797Glioma 1130Central Nervous System Neoplasms 599Astrocytoma 594Neuroblastoma 552Gliosarcoma 465Oligodendroglioma 364Neoplasms 312Breast Neoplasms 273Medulloblastoma 272Carcinoma, Non-Small-Cell Lung 227Recurrence 199Sarcoma 184Neoplasm Metastasis 183Melanoma 182Meningioma 177Ependymoma 176Lung Neoplasms 157Lymphoma 134Osteosarcoma 127Meningeal Carcinomatosis 126Neurofibromatosis 1 114Wilms Tumor 111Ovarian Neoplasms 110Diffuse Intrinsic Pontine Glioma 105Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Rhabdomyosarcoma 101Lymphoma, Non-Hodgkin 96Burkitt Lymphoma 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Metabolic Syndrome × CNS × Clear all
NCT04706676 2025-06-11

INTERACT

Rigshospitalet, Denmark

Phase NA Active not recruiting
132 enrolled
CNSLymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Motor Activity, Neoplasms, Central Nervous System Neoplasms, Metabolic Syndrome

NCT03708913 2020-11-02

Neuromodulation for Hypothalamic Obesity

University of British Columbia

Phase NA Withdrawn
CNS

Craniopharyngioma, Metabolic Syndrome, Sexual Infantilism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡